N-4-Aminobenzoyl-(beta)-alanine (CAS No. 7377-08-4) is a metabolite of balsalazide, an anti-inflammatory drug used in the treatment of inflammatory bowel disease. Balsalazide is marketed under the brand names ‘Colazal’ in the US and ‘Colazide’ in the UK, and is also available in generic form in the US from various manufacturers. Typically administered as the disodium salt, balsalazide releases mesalazine (also known as 5-aminosalicylic acid or 5-ASA) in the large intestine.
This compound is classified as a beta-amino acid and its derivatives, which are amino acids containing a (-NH2) group attached to the beta carbon atom.
